AnalystBook Research · Company Intelligence

Anterix Inc.

ATEXNasdaq

Built from Anterix Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

ATEX improved earnings while revenue moved higher.

The read at a glance✓ Audited against SEC data
  • Business mixlicensed 900 MHz spectrum company for critical in...Note
  • Revenue$6.50M, +7.8%OK
  • Net income$90.64M, +897.0%OK
  • FCF$5.48M, +118.7%OK
  • Altman/Beneish/EQGrey Z; M N/A; EQ N/ANote
  • Insiders4 purchases / 7 salesOK

Business

Anterix Inc. is a licensed 900 MHz spectrum company for critical infrastructure connectivity.

Where the revenue comes from

Fiscal 2026, as Anterix Inc. reports it. History and quarterly detail are in the app.

  • Total spectrum revenue$6.5M

Leadership changes

From Anterix Inc.'s own filings, the day they're filed.

  • Ryan Gerbrandt · Chief Operating Officer · departureeff. 2026-01-09
  • A. Gray · Chief Financial Officer · departureeff. 2025-09-19
  • Elena Marquez · Chief Financial Officer · departureeff. 2025-09-19

Latest filings

  • 8-K · Company announcement2026-08-11
  • 10-Q · Quarterly report2026-08-11
  • 8-K · Company announcement2026-08-06
  • 10-K · Annual report2026-06-25
  • DEF 14A · Annual proxy (pay & governance)2026-06-25
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Anterix Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.